GUFICBIO427.80

Gufic Biosciences Limited

· Pharma & Health
₹ CrorePeersRPGLIFEUNICHEMLABGUJTHEMORCHPHARMASMSPHARMAINDSWFTLABFDCIOLCPMcap ₹4,290 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt317.0310.4385.2385.2
Net Debt315.9294.7323.0323.0
Total Debt/Equity0.600.520.580.58
Net Debt/Equity0.590.490.490.49
Total Debt/EBITDA2.172.302.552.55
Net Debt/EBITDA2.172.192.131.96
Interest Coverage (EBIT/Interest)8.394.923.293.29
Total Debt/Total Capital %37.3234.0536.6836.68
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.